ABSTRACT
Objective To provide evidence on the effect of the COVID-19 pandemic on the mental health of adolescents and young adults who grew up in poverty in Low and Middle Income Countries (LMICs).
Design A phone survey implemented August-October 2020 to participants of a population-based cohort study since 2002 comprising two cohorts born in 1994-5 and 2001-2 in Ethiopia, India (Andhra Pradesh and Telangana), Peru and Vietnam. We examined associations between mental health and pandemic-related stressors, as well as structural factors (gender, location, wealth); and lifelong protective/risk factors (parent and peer relationship, past household wealth, long-term health problems, past emotional problems and subjective well-being) measured at younger ages.
Setting A diverse, poverty focused sample, reaching those without mobile phones or internet access.
Participants 10,496 individuals were approached, 9,730 participated. Overall, 8,988 individuals were included in this study, 4,610 (51%) male and 4,378 (49%) female. Non-inclusion was due to non-location or missing data.
Main outcome measures At least mild anxiety and depression were measured by Generalized Anxiety Disorder-7 (GAD-7, ≥5) and Patient Health Questionnaire-8 (PHQ-8, ≥5).
Results Rates of symptoms of at least mild anxiety (depression) were highest in Peru at 41% (32%) [95% CI, 38.63-43.12; (29.49-33.74)], and lowest in Vietnam at 9% (9%) [95% CI, 8.16-10.58; (8.33-10.77)], mirroring COVID-19 mortality rates. Females were most affected in all countries but Ethiopia. In all countries, pandemic-related stressors were associated with increased rates of anxiety and depression, though with varying levels of importance across countries. Prior parent and peer relationships were protective factors for mental health while having a long-term health problem or prior emotional problems were risk factors.
Conclusion The COVID-19 pandemic presents significant risks to the mental health of young people. Mental health support is limited in LMICs and young people have to date been lower priority for COVID-19 interventions.
Strengths and limitations of this study
The study uses data from adolescents and young adults who grew up in poverty in four LMICs which were diversely affected by the COVID-19 pandemic, therefore investigating a globally vulnerable, but understudied group both in terms of age and wealth.
This study reaches a broad sample of young people who grew up in poverty, including those without internet or mobile phone access.
A key strength is combining a broad range of pandemic-related stressors from survey data on experiences of COVID-19 with previously measured information on longer-term risk and protective factors, therefore contributing to a more complete picture of COVID-19 effects.
A limitation of the study is that it does not have a directly comparable pre-COVID baseline for depression/anxiety, however, proxy variables are used as a baseline and the explanatory variables capture dynamics that happened during the pandemic.
A further limitation is possible underreporting due to stigma associated with mental health, despite piloting and validation, as well as possible bias in self-reported experiences of pandemic-related stressors due to feelings of anxiety or depression.
Competing Interest Statement
CP, MF, AH, DS, ASJ, RE, TW and LTD report grants from the Foreign, Commonwealth and Development Office (FCDO), during the conduct of the study. MC and AS have nothing to disclose.
Clinical Trial
Cohort survey so no clinical registry needed
Funding Statement
Young Lives at Work is funded by UK aid from the Foreign, Commonwealth and Development Office (FCDO), under Department for International Development, UK Government grant number 200425. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The views expressed are those of the authors. They are not necessarily those of, or endorsed by, the University of Oxford, Young Lives, FCDO. All authors had full access to the anonymized data in the study and had final responsibility for the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Oxford University, Oxford Department of International Development, Departmental Research Ethics Committee (DREC). Research Ethics Approval - Ref No: CUREC 1A/ ODID CIA-20-034 (15th May 2020). The survey was approved by the institutional research ethics committees at the University of Oxford (UK), the University of Addis Ababa (Ethiopia), the Centre for Economic and Social Studies in Hyderabad (India), the Instituto de Investigacion Nutricional (Peru) and the Hanoi University of Public Health (Vietnam). Participants were asked for their verbal informed consent before the study commenced and were assured of confidentiality. A consultation guide was provided to all participants with resources for support in issues raised by the questionnaire, including mental health.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.